Lisata Therapeutics, Inc. (FRA:8NE)

Germany flag Germany · Delayed Price · Currency is EUR
3.720
+0.380 (11.38%)
Last updated: Jan 28, 2026, 8:12 AM CET
48.80%
Market Cap34.38M +13.3%
Revenue (ttm)911.96K
Net Income-15.55M
EPS-1.81
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume50
Open3.720
Previous Close3.340
Day's Range3.720 - 3.720
52-Week Range1.500 - 3.720
Betan/a
RSI88.79
Earnings DateFeb 27, 2026

About Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is hea... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1980
Employees 26
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8NE
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements